Viewing Study NCT00784303


Ignite Creation Date: 2025-12-24 @ 7:23 PM
Ignite Modification Date: 2025-12-30 @ 12:05 AM
Study NCT ID: NCT00784303
Status: COMPLETED
Last Update Posted: 2020-04-22
First Post: 2008-10-30
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Evaluating the Safety and Efficacy of Oral Lenvatinib in Medullary and Iodine-131 Refractory, Unresectable Differentiated Thyroid Cancers, Stratified by Histology
Sponsor: Eisai Inc.
Organization: